MDMA Successfully Treats PTSD in Another Phase 3 Trial Sponsored by MAPS
“MDMA-assisted therapy for PTSD is on track to be considered for approval by the FDA in 2024,” says MAPS founder and president Rick Doblin.
“MDMA-assisted therapy for PTSD is on track to be considered for approval by the FDA in 2024,” says MAPS founder and president Rick Doblin.
“There are countless first responders, veterans and people across California who could benefit,” says a retired New York City fireman.
My psychedelic MDMA experience put me into a hole of paranoia and dysregulation. Here’s what it took for me to climb out of it
What is ayahuasca, and what does it have to do with a church? Here’s my ayahuasca experience in the Soul Quest Church.
Jessika Lagarde, the co-founder of Women on Psychedelics, explores how various psychoactive substances can treat mental health issues including depression, eating disorders, PTSD, and addiction.
TeleSage uses the SAGE-SR protocol to offer holistic assessments essential for integrated psychedelic medicine
Empower Psychedelics is raising awareness for physical fitness as a key component of therapeutic recovery and rehabilitation
The road to psychedelic legalization has many paths. These 3 clinical trials have the best chances to legalize psychedelics for therapy
Deficiancies in good clinical practices and accurate record keeping stops an MDMA clinical trial in its tracks
GoDaddy Founder Bob Parsons talks to Psychedelic Spotlight about treating PTSD with MDMA-assisted psychedelic therapy
End of content
End of content
By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.